Bio-Rad Laboratories Book Value Per Share Growth & History (BIO)
Bio-Rad Laboratories's book value per share was $276.16 for fiscal 2025.
View full Bio-Rad Laboratories company overviewBio-Rad Laboratories annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $276.16 | $41.63 | +17.75% |
| 2024 | 2024-12-31 | $234.52 | -$71.99 | −23.49% |
| 2023 | 2023-12-31 | $306.51 | -$18.37 | −5.66% |
| 2022 | 2022-12-31 | $324.88 | -$133.87 | −29.18% |
| 2021 | 2021-12-31 | $458.76 | $126.53 | +38.09% |
| 2020 | 2020-12-31 | $332.23 | $139.32 | +72.22% |
| 2019 | 2019-12-31 | $192.90 | $58.16 | +43.16% |
| 2018 | 2018-12-31 | $134.75 | $35.94 | +36.37% |
| 2017 | 2017-12-31 | $98.81 | $11.20 | +12.79% |
| 2016 | 2016-12-31 | $87.61 | $2.46 | +2.89% |
| 2015 | 2015-12-31 | $85.14 | $9.53 | +12.60% |
| 2014 | 2014-12-31 | $75.62 | -$0.88 | −1.15% |
| 2013 | 2013-12-31 | $76.50 | $5.27 | +7.40% |
| 2012 | 2012-12-31 | $71.23 | $9.01 | +14.49% |
| 2011 | 2011-12-31 | $62.21 | $6.67 | +12.00% |
| 2010 | 2010-12-31 | $55.55 | $9.58 | +20.84% |
| 2009 | 2009-12-31 | $45.97 | $6.48 | +16.41% |
| 2008 | 2008-12-31 | $39.49 | — | — |
Bio-Rad Laboratories quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $268.30 | $4.88 | +1.85% |
| Q1 2026 | 2026-03-31 | $255.37 | $16.32 | +6.83% |
| Q4 2025 | 2025-12-31 | $276.16 | — | — |
| Q3 2025 | 2025-09-30 | $249.75 | -$18.16 | −6.78% |
| Q2 2025 | 2025-06-30 | $263.42 | $24.68 | +10.34% |
| Q1 2025 | 2025-03-31 | $239.05 | -$78.34 | −24.68% |
| Q3 2024 | 2024-09-30 | $267.91 | -$21.28 | −7.36% |
| Q2 2024 | 2024-06-30 | $238.74 | -$49.01 | −17.03% |
| Q1 2024 | 2024-03-31 | $317.39 | -$12.51 | −3.79% |
| Q3 2023 | 2023-09-30 | $289.20 | $4.08 | +1.43% |
| Q2 2023 | 2023-06-30 | $287.75 | -$12.48 | −4.16% |
| Q1 2023 | 2023-03-31 | $329.90 | -$10.97 | −3.22% |
| Q3 2022 | 2022-09-30 | $285.12 | -$229.15 | −44.56% |
| Q2 2022 | 2022-06-30 | $300.23 | -$89.33 | −22.93% |
| Q1 2022 | 2022-03-31 | $340.87 | -$14.86 | −4.18% |
| Q3 2021 | 2021-09-30 | $514.27 | $217.33 | +73.19% |
| Q2 2021 | 2021-06-30 | $389.56 | $141.57 | +57.09% |
| Q1 2021 | 2021-03-31 | $355.73 | $145.02 | +68.82% |
| Q3 2020 | 2020-09-30 | $296.93 | $124.92 | +72.63% |
| Q2 2020 | 2020-06-30 | $247.99 | $63.96 | +34.75% |
| Q1 2020 | 2020-03-31 | $210.72 | $47.51 | +29.11% |
| Q3 2019 | 2019-09-30 | $172.01 | $7.91 | +4.82% |
| Q2 2019 | 2019-06-30 | $184.03 | $28.44 | +18.28% |
| Q1 2019 | 2019-03-31 | $163.21 | $12.54 | +8.32% |
| Q3 2018 | 2018-09-30 | $164.10 | $68.06 | +70.87% |
| Q2 2018 | 2018-06-30 | $155.60 | $60.67 | +63.92% |
| Q1 2018 | 2018-03-31 | $150.67 | $59.14 | +64.62% |
| Q3 2017 | 2017-09-30 | $96.04 | $4.25 | +4.63% |
| Q2 2017 | 2017-06-30 | $94.92 | $5.99 | +6.73% |
| Q1 2017 | 2017-03-31 | $91.53 | $4.88 | +5.63% |
| Q3 2016 | 2016-09-30 | $91.79 | $8.57 | +10.29% |
| Q2 2016 | 2016-06-30 | $88.94 | $7.98 | +9.85% |
| Q1 2016 | 2016-03-31 | $86.65 | $11.08 | +14.66% |
| Q3 2015 | 2015-09-30 | $83.22 | $7.86 | +10.43% |
| Q2 2015 | 2015-06-30 | $80.96 | $2.91 | +3.73% |
| Q1 2015 | 2015-03-31 | $75.57 | -$1.97 | −2.55% |
| Q3 2014 | 2014-09-30 | $75.36 | $1.09 | +1.47% |
| Q2 2014 | 2014-06-30 | $78.05 | $5.48 | +7.56% |
| Q1 2014 | 2014-03-31 | $77.55 | $6.26 | +8.78% |
| Q3 2013 | 2013-09-30 | $74.27 | $5.92 | +8.67% |
| Q2 2013 | 2013-06-30 | $72.57 | $7.01 | +10.70% |
| Q1 2013 | 2013-03-31 | $71.29 | $6.05 | +9.28% |
| Q3 2012 | 2012-09-30 | $68.34 | $8.03 | +13.31% |
| Q2 2012 | 2012-06-30 | $65.55 | $3.95 | +6.41% |
| Q1 2012 | 2012-03-31 | $65.23 | $7.45 | +12.90% |
| Q3 2011 | 2011-09-30 | $60.31 | $8.91 | +17.33% |
| Q2 2011 | 2011-06-30 | $61.61 | $15.16 | +32.63% |
| Q1 2011 | 2011-03-31 | $57.78 | — | — |
| Q3 2010 | 2010-09-30 | $51.41 | — | — |
| Q2 2010 | 2010-06-30 | $46.45 | — | — |
Bio-Rad Laboratories book value per share trends
Over the last five fiscal years, Bio-Rad Laboratories's book value per share decreased from $332.23 to $276.16, a change of -$56.07. The latest reported quarter, Q2 2026, shows $268.30.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bio-Rad Laboratories source filings ↗